Medindia LOGIN REGISTER
Medindia
Advertisement

Biohaven Announces Exclusive License With Catalent For Zydis® Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists

Wednesday, February 21, 2018 Medico Legal News
Advertisement
Catalent’s Zydis® Fast Dissolve Technology Platform

Sponsored Post and Backlink Submission


Latest Press Release on Medico Legal News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close